Journal of Cancer Research and Clinical Oncology

A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment
pp. 1303-1314(12)
Authors: Marcu, Loredana; Yeoh, E.

A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland
pp. 1315-1321(7)
Authors: He, Hong; Chen, Guanfu; Zhou, Liang; Liu, Yanmin

Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer
pp. 1323-1330(8)
Authors: Xu, Wei-Qing; Song, Ling-Jun; Liu, Qiang; Zhao, Lei; Zheng, Lin; Yan, Zhao-Wen; Fu, Guo-Hui

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance
pp. 1331-1339(9)
Authors: Yu, Guan; Chen, Ying; Wang, Jie

Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma
pp. 1341-1349(9)
Authors: Yang, Xiaoya; Xiong, Gang; Chen, Xuedan; Xu, Xueqing; Wang, Kai; Fu, Yong; Yang, Kang; Bai, Yun

B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?
pp. 1351-1358(8)
Authors: Richter, Petra; Tost, Markus; Franz, Marcus; Altendorf-Hofmann, Annelore; Junker, Kerstin; Borsi, Laura; Neri, Dario; Kosmehl, Hartwig; Wunderlich, Heiko; Berndt, Alexander

High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection
pp. 1359-1367(9)
Authors: Hu, Jie; Xu, Yang; Shen, Zao-Zhuo; Wang, Zheng; Lu, Qing; Yang, Guo-Huan; Ding, Zheng-Bin; Fan, Jia; Zhou, Jian

ABCG2 is related with the grade of glioma and resistance to mitoxantone, a chemotherapeutic drug for glioma
pp. 1369-1376(8)
Authors: Jin, Yao; Bin, Zhang; Qiang, Huang; Liang, Chu; Hua, Chen; Jun, Dong; Dong, Wang; Qing, Lan

Antitumor activity of the HER2 dimerization inhibitor pertuzumab on human colon cancer cells in vitro and in vivo
pp. 1377-1386(10)
Authors: Pohl, Michael; Stricker, I.; Schoeneck, A.; Schulmann, K.; Klein-Scory, S.; Schwarte-Waldhoff, I.; Hasmann, M.; Tannapfel, A.; Schmiegel, W.; Reinacher-Schick, A.

Interdisciplinary S2k guidelines on the diagnosis and treatment of endometrial carcinoma
pp. 1387-1391(5)
Authors: Emons, Günter; Kimmig, Rainer

Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer
pp. 1393-1401(9)
Authors: Wang, Xiao-Chun; Tian, Li-Li; Tian, Jing; Wu, Hai-Liang; Meng, Ai-min

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
pp. 1403-1412(10)
Authors: Fan, Jia; Yang, Guang-Shun; Fu, Zhi-Ren; Peng, Zhi-Hai; Xia, Qiang; Peng, Chen-Hong; Qian, Jian-Ming; Zhou, Jian; Xu, Yang; Qiu, Shuang-Jian; Zhong, Lin; Zhou, Guang-Wen; Zhang, Jian-Jun

Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications
pp. 1413-1420(8)
Authors: Tseng, Hsi-Huang; Chang, Jan-Gowth; Hwang, Yaw-Huei; Yeh, Kun-Tu; Chen, Yao-Li; Yu, Hsin-Su

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP
pp. 1421-1428(8)
Authors: Hara, Takeshi; Tsurumi, Hisashi; Goto, Naoe; Kanemura, Nobuhiro; Yoshikawa, Takeshi; Kasahara, Senji; Yamada, Toshiki; Sawada, Michio; Goto, Hideko; Fukuno, Kenji; Kitagawa, Jun-ichi; Yasuda, Ichiro; Katsumura, Naoki; Takemura, Masao; Takahashi, Takeshi; Takami, Tsuyoshi; Moriwaki, Hisataka

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
pp. 1429-1435(7)
Authors: Wilop, Stefan; Hobe, Sabine; Crysandt, Martina; Esser, Albert; Osieka, Rainhardt; Jost, Edgar

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma
pp. 1437-1445(9)
Authors: Zhong, Chong; Guo, Rong-ping; Li, Jin-qing; Shi, Ming; Wei, Wei; Chen, Min-shan; Zhang, Ya-qi

The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma
pp. 1447-1453(7)
Authors: Zhang, Ning; Wang, Lu; Liang, Ying; Zhao, Yi-Ming; Xue, Qiong; Wu, Wei-Zhong; Sun, Hui-Chuan; Fan, Jia; Tang, Zhao-You

Endothelin-A-receptor antagonism with atrasentan exhibits limited activity on the KU-19-19 bladder cancer cell line in a mouse model
pp. 1455-1462(8)
Authors: Herrmann, Edwin; Tiemann, Arne; Eltze, Elke; Bolenz, Christian; Bremer, Christoph; Persigehl, Thorsten; Hertle, Lothar; Wülfing, Christian

APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
pp. 1463-1470(8)
Authors: Andresen, Per; Heimdal, Ketil; Aaberg, Kristin; Eklo, Kristin; Ariansen, Sarah; Silye, Alexandra; Fausa, Olav; Aabakken, Lars; Aretz, Stefan; Eide, Tor; Gedde-Dahl, Tobias

APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
pp. 1471-1471(1)
Authors: Andresen, Per; Heimdal, Ketil; Aaberg, Kristin; Eklo, Katrine; Ariansen, Sarah; Silye, Alexandra; Fausa, Olav; Aabakken, Lars; Aretz, Stefan; Eide, Tor; Gedde-Dahl, Tobias